ABBV vs TECH
By Alex · Tickerpine
AbbVie Inc. vs Bio-Techne Corporation, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | ABBV | TECH |
|---|---|---|
| Price | $285.64 | $72.55 |
| Market cap | $504.76B | $11.38B |
| P/E ratio | 80.5 | 62.5 |
| ROE | — | 9.03% |
| Profit margin | 9.80% | 14.97% |
| Revenue growth | 10.20% | 1.30% |
| Dividend yield | 2.42% | 0.44% |
| Beta | 0.23 | 1.29 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
ABBV vs TECH in plain English
- ABBV is the bigger company — about 44.4× the market cap of TECH.
- TECH is cheaper on earnings (P/E 62.5 vs 80.5).
- ABBV is growing revenue faster (10% vs 1%).
- ABBV has the higher dividend yield (2.42% vs 0.44%).
How would $1,000 have done in each?
ABBV return calculator
See what $1,000 in AbbVie Inc. would be worth today.
TECH return calculator
See what $1,000 in Bio-Techne Corporation would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.